Carlos Bonilla
Corporate Officer/Principal chez Carlos J. Bonilla & Associates PL
Fortune : 1 M $ au 31/05/2024
Profil
Carlos J.
Bonilla is currently the Principal of Mr. Bonilla & Associates PL.
Previously, he worked as a Director at XenaCare Holdings, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LA ROSA HOLDINGS CORP.
6,82% | 16/04/2024 | 1 010 840 ( 6,82% ) | 1 M $ | 31/05/2024 |
Postes actifs de Carlos Bonilla
| Sociétés | Poste | Début |
|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 12/05/2011 |
Anciens postes connus de Carlos Bonilla
| Sociétés | Poste | Fin |
|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
